文献速递心脑血管急症重症综合管理与镇静镇痛

脑微透析代谢物及血乳酸、血糖水平与院外心脏骤停后神经功能结局的关系:一项初步微透析研究

Association of brain metabolites with blood lactate and glucose levels with respect to neurological outcomes after out-of-hospital cardiac arrest: A preliminary microdialysis study.
PubMed 文献 · Resuscitation · 2016-10-27
一句话结论院外心脏骤停后治疗性低温期间,不良神经结局组脑微透析乳酸/丙酮酸比值进行性升高,第2、3、4天差异有统计学意义(p<0.01)。

这项回顾性初步研究纳入10例在香川大学医院收治并接受治疗性低温的院外心脏骤停患者,使用脑微透析探头在治疗性低温最初72小时内每小时测定脑细胞外葡萄糖、乳酸和丙酮酸水平,同时监测颅内压和脑灌注压,计算乳酸/丙酮酸比值。按心脏骤停后30天格拉斯哥-匹兹堡脑功能表现分级1-2分(良好)与3-5分(不良)分组比较。结果显示不良结局组颅内压显著更高、脑微透析乳酸/丙酮酸比值进行性升高(第2、3、4天p<0.01)、血乳酸仅第3.5天有显著差异、治疗性低温期间脑微透析和血葡萄糖水平更高。作者认为脑微透析水平与长期结局的关联需大型随机前瞻性研究进一步明确。

要点

  • 院外心脏骤停后治疗性低温期间,不良神经结局组脑微透析乳酸/丙酮酸比值进行性升高,第2、3、4天与良好结局组差异有统计学意义(p<0.01)。
  • 不良神经结局组颅内压显著高于良好结局组,而两组脑灌注压无显著差异。
  • 血乳酸水平仅在治疗性低温第3.5天两组间有显著差异。
  • 治疗性低温期间不良神经结局组的脑微透析葡萄糖和血葡萄糖水平均高于良好结局组。
  • 本研究为10例回顾性初步研究,作者认为脑微透析水平与长期结局的关联需大型随机前瞻性研究进一步明确。

适用人群与场景

  • 在香川大学医院收治并接受治疗性低温的院外心脏骤停患者,共10例。
  • 按心脏骤停后30天格拉斯哥-匹兹堡脑功能表现分级分为良好结局组(1-2分)与不良结局组(3-5分)。

诊断标准与关键阈值

  • 神经功能结局分组标准:心脏骤停后30天格拉斯哥-匹兹堡脑功能表现分级1-2分为良好神经结局,3-5分为不良神经结局。

处置流程与药物剂量

  • 使用脑微透析探头在治疗性低温最初72小时内每小时测定脑细胞外葡萄糖、乳酸和丙酮酸水平,并计算乳酸/丙酮酸比值。
  • 治疗性低温最初72小时内同时监测颅内压和脑灌注压。

研究设计与关键结果

  • 研究类型:回顾性初步研究;样本量10例;人群:香川大学医院收治并接受治疗性低温的院外心脏骤停患者。
  • 颅内压不良神经结局组显著高于良好结局组;脑灌注压两组间无显著差异。
  • 脑微透析乳酸/丙酮酸比值不良结局组进行性升高,第2、3、4天两组差异有统计学意义(p<0.01)。
  • 血乳酸水平仅在治疗性低温第3.5天两组间有显著差异。
  • 治疗性低温期间脑微透析葡萄糖和血葡萄糖水平不良结局组高于良好结局组。

证据类型、等级与局限

  • 证据类型:回顾性初步研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,脑微透析水平与长期结局的关联需大型随机前瞻性研究进一步明确。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: Out-of-hospital cardiac arrest (OHCA) is associated with poor prognosis. Cerebral microdialysis (CMD) is an efficient sampling technique to detect neurochemical changes in brain interstitial tissue. In this retrospective study, we hypothesised that there are different CMD levels between patients with favourable and unfavourable neurological outcomes.

METHODS: Data of patients with OHCA admitted to Kagawa University Hospital and administered therapeutic hypothermia (TH) were collected. Using a CMD probe, extracellular glucose, lactate and pyruvate levels were measured hourly along with intracranial perfusion pressure (ICP) and cerebral perfusion pressure (CPP) for the initial 72h during TH. The lactate/pyruvate (LP) ratio was calculated. Patients were divided into favourable [Glasgow-Pittsburgh cerebral performance category 1-2 at 30days after cardiac arrest] or unfavourable neurological outcome groups. CMD biochemical markers and blood lactate and glucose levels were compared between two groups.

RESULTS: Ten patients were included. ICP was significantly higher in the unfavourable than in the favourable neurological outcome group; there were no significant differences with respect to CPP. The CMD LP ratio in the unfavourable outcome group progressively increased; significant differences were observed on days 2, 3 and 4 (p<0.01). Significant differences in blood lactate levels were observed between the groups only on day 3.5. CMD and blood glucose levels were higher in the unfavourable than in the favourable outcome group during TH.

CONCLUSION: The association of CMD levels with long-term outcomes would be better defined in a large randomised prospective study.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Hifumi T, Kawakita K, Yoda T, et al. Association of brain metabolites with blood lactate and glucose levels with respect to neurological outcomes after out-of-hospital cardiac arrest: A preliminary microdialysis study. Resuscitation. 2016. PMID: 27984152. doi:10.1016/j.resuscitation.2016.10.013

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。